🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
CCOP - Scottsdale Oncology Program
Start Date
1994-01
Trial ID
NCT00002548
This phase II trial studies how well giving abiraterone acetate and prednis...
Status
Unknown
Location
USC Norris Comprehensive Cancer Center
Start Date
2012-09
Trial ID
NCT01685125
Treatments Being Tested
This is a phase II clinical trial in patients with metastatic castration se...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2019-10-10
Trial ID
NCT03934840
Treatments Being Tested
Study of ONTAK and CHOP (chemotherapy drugs) to find out their ability to m...
Status
Completed
Location
Birmingham Hematology and Oncology
Start Date
2004-03-14
Trial ID
NCT00211185
Treatments Being Tested
This is a randomized, open-label, multi-center, phase 2 study of RCHOP with...
Status
Completed
Location
Tower Cancer Research Foundation
Start Date
2009-10
Trial ID
NCT00931918
Treatments Being Tested
The purpose of this study is to evaluate the feasibility, safety and oncolo...
Status
Unknown
Location
Guangdong Provincial Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine
Start Date
2018-09-23
Trial ID
NCT03587285
Treatments Being Tested
This is a randomized, multi-center, open-label Phase II clinical trial to d...
Status
Withdrawn
Location
Geisinger Medical Center
Start Date
2012-09
Trial ID
NCT01524068
Treatments Being Tested
This is a phase II prospective non-randomised clinical trial in newly diagn...
Status
Completed
Location
Aarhus University Hospital
Start Date
2001-10
Trial ID
NCT00791947
Treatments Being Tested
The purpose of this study is to assess whether patients who are likely to f...
Status
Unknown
Location
BC Cancer Agency
Start Date
2006-08
Trial ID
NCT00324467
The purpose of this study is to assess whether co-administration of belimum...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-03-01
Trial ID
NCT03312907